Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by

Pharma R&D

girl-2239965_960_720

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by

Pharma R&D

lab-385348_960_720

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. Continue reading “As Drug Development Costs Skyrocket, AI Offers Some Hope” »

Myelo Therapeutics Takes on Unmet Needs in Cancer

Posted on November 17th, 2017 by

Pharma R&D

Till-Erdmann-and-Dirk-Pleimes

Many pharmaceutical and biotechnology start-ups have been founded for the purpose of taking on unmet needs. It has often been difficult for the larger, more established pharma companies to focus on these narrower problems, so the leaner, scrappier start-ups are putting their passion and brainpower to the challenges that have yet to be tackled. Continue reading “Myelo Therapeutics Takes on Unmet Needs in Cancer” »

Disrupting innovation: From geography, penguins and ocean currents to diagnosing disease by its smell

Posted on November 15th, 2017 by

Pharma R&D

banner-1235602_640

How to become aware of what I don’t know? These insights can stimulate disruption. They help us see a whole new world or perhaps a pattern of activities that need to change. As Donald Rumsfeld described, it is those things we don’t know we don’t know that can be issues for the future. They can also be lost opportunities in scientific understanding and commercial success. Continue reading “Disrupting innovation: From geography, penguins and ocean currents to diagnosing disease by its smell” »

Managing Data and the Digital Revolution with Emerging Technologies

Posted on November 13th, 2017 by

Pharma R&D

abstract-1278056_640

The scholarly publishing industry has experienced major shifts in the last few decades. Research journals have long captured the insights of scientific research, further fueling the work of other scientists. Continue reading “Managing Data and the Digital Revolution with Emerging Technologies” »

Considering lifestyle and environment to maximize the economic value of R&D

Posted on November 10th, 2017 by

Pharma R&D

human-digestive-system-163714_640

With an interest in systems approaches, I am always on the look-out for interesting papers in this area. A recent paper in Drug Discovery Today caught my eye for several reasons (1). The first was the extent of the problem with non-alcoholic liver disease. Continue reading “Considering lifestyle and environment to maximize the economic value of R&D” »

  1. 1
  2. 2
  3. 3
  4. 51


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.